Drugs Made In America Acquisition II Corp. DMII
10.21 USD -0.01 (-0.10%)
At closeNov 6, 2026, 4:00 PM EST
10.21 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
10.21 Day range 10.21
9.87 52-week range 10.23
- YTD
- +3.13%
- 1 year
- +3.34%
Financial health
Rating
B-3 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 4
- Debt / Equity 5
- P/E 1
- P/B 3
Valuation
P/E 61.9×
FY 2024 5y median -2027× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B 0.3×
FY 2024 5y median -2696× FY 2025
P/FCF -129×
FY 2024 5y median -1684× FY 2025
EV/EBITDA -101×
FY 2024 5y median -2125× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -0.8%
FY 2024 5y median -0.4% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 0.9%
FY 2024 5y median 65.4% FY 2025
ROIC -0.3%
FY 2024 5y median -57.0% FY 2025
ROA 0.8%
FY 2024 5y median -54.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -757.2%
FY 2024 FY 2025
EPS (diluted) 6350.0%
FY 2024 FY 2025
Free Cash Flow -424.1%
FY 2024 FY 2025
Financial Health
Current Ratio 0.1×
FY 2024 5y median 0.2× FY 2025
Quick Ratio 0.1×
FY 2024 5y median 0.2× FY 2025
Debt / Equity 0.0×
FY 2024 5y median -1.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2024 5y median -0.8× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31